Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 1
1956 2
1958 1
1959 6
1960 2
1961 2
1962 3
1964 3
1965 5
1966 2
1967 5
1968 3
1969 3
1970 4
1971 9
1972 5
1973 3
1974 6
1975 7
1976 4
1977 11
1978 12
1979 16
1980 17
1981 16
1982 20
1983 18
1984 16
1985 13
1986 20
1987 17
1988 23
1989 19
1990 21
1991 20
1992 23
1993 30
1994 29
1995 25
1996 45
1997 59
1998 62
1999 75
2000 93
2001 86
2002 112
2003 111
2004 131
2005 154
2006 158
2007 185
2008 219
2009 262
2010 284
2011 357
2012 379
2013 413
2014 451
2015 446
2016 423
2017 435
2018 452
2019 485
2020 535
2021 581
2022 579
2023 544
2024 409
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

8,007 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.
Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. Among authors: chung cf. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, Garcia JJ, Chung CH, Gillison ML, Duvvuri U, O'Malley BW Jr, Ozer E, Thomas GR, Koch WM, Gross ND, Bell RB, Saba NF, Lango M, Méndez E, Burtness B. Ferris RL, et al. Among authors: chung ch. J Clin Oncol. 2022 Jan 10;40(2):138-149. doi: 10.1200/JCO.21.01752. Epub 2021 Oct 26. J Clin Oncol. 2022. PMID: 34699271 Free PMC article. Clinical Trial.
Reply.
Sanyal AJ, Chung C, Myers RP, Bosch J. Sanyal AJ, et al. Among authors: chung c. Hepatology. 2022 Jul;76(1):E5-E6. doi: 10.1002/hep.32373. Epub 2022 Apr 18. Hepatology. 2022. PMID: 35102590 No abstract available.
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma.
Chung CH, Li J, Steuer CE, Bhateja P, Johnson M, Masannat J, Poole MI, Song F, Hernandez-Prera JC, Molina H, Wenig BM, Kumar S, Kuperwasser C, Stephens PJ, Farinhas JM, Shin DM, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF, Bonomi M. Chung CH, et al. Clin Cancer Res. 2022 Jun 1;28(11):2329-2338. doi: 10.1158/1078-0432.CCR-21-3849. Clin Cancer Res. 2022. PMID: 35344035 Free PMC article. Clinical Trial.
Case 296.
Lu CY, Tseng PC, Chen KC, Huang CC, Tsang YM, Lee TH, Lin CK, Chung CS. Lu CY, et al. Among authors: chung cs. Radiology. 2021 Aug;300(2):481-483. doi: 10.1148/radiol.2021201790. Radiology. 2021. PMID: 34310227
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.
Mautner K, Gottschalk M, Boden SD, Akard A, Bae WC, Black L, Boggess B, Chatterjee P, Chung CB, Easley KA, Gibson G, Hackel J, Jensen K, Kippner L, Kurtenbach C, Kurtzberg J, Mason RA, Noonan B, Roy K, Valentine V, Yeago C, Drissi H. Mautner K, et al. Among authors: chung cb. Nat Med. 2023 Dec;29(12):3120-3126. doi: 10.1038/s41591-023-02632-w. Epub 2023 Nov 2. Nat Med. 2023. PMID: 37919438 Free PMC article. Clinical Trial.
Knee Cartilage Imaging.
Cheng KY, Lombardi AF, Chang EY, Chung CB. Cheng KY, et al. Among authors: chung cb. Clin Sports Med. 2021 Oct;40(4):677-692. doi: 10.1016/j.csm.2021.05.006. Clin Sports Med. 2021. PMID: 34509205 Review.
Genetic Inhibition of APOL1 Pore-Forming Function Prevents APOL1-Mediated Kidney Disease.
Hung AM, Assimon VA, Chen HC, Yu Z, Vlasschaert C, Triozzi JL, Chan H, Wheless L, Wilson O, Shah SC, Mack T, Thompson T, Matheny ME, Chandrasekar S, Mozaffari SV, Chung CP, Tsao P, Susztak K, Siew ED, Estrada K, Gaziano JM, Graham RR, Tao R, Hoek M, Robinson-Cohen C, Green EM, Bick AG; Million Veteran Program. Hung AM, et al. Among authors: chung cp. J Am Soc Nephrol. 2023 Nov 1;34(11):1889-1899. doi: 10.1681/ASN.0000000000000219. Epub 2023 Oct 6. J Am Soc Nephrol. 2023. PMID: 37798822
8,007 results